Logo image of CLI.MI

CENTRALE DEL LATTE D'ITALIA (CLI.MI) Stock Fundamental Analysis

BIT:CLI - Euronext Milan - IT0003023980 - Common Stock - Currency: EUR

3.04  +0.16 (+5.56%)

Fundamental Rating

5

Taking everything into account, CLI scores 5 out of 10 in our fundamental rating. CLI was compared to 58 industry peers in the Food Products industry. There are concerns on the financial health of CLI while its profitability can be described as average. CLI is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

CLI had positive earnings in the past year.
CLI had a positive operating cash flow in the past year.
Each year in the past 5 years CLI has been profitable.
CLI had a positive operating cash flow in each of the past 5 years.
CLI.MI Yearly Net Income VS EBIT VS OCF VS FCFCLI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

CLI has a Return On Assets of 3.80%. This is comparable to the rest of the industry: CLI outperforms 51.72% of its industry peers.
With a decent Return On Equity value of 14.22%, CLI is doing good in the industry, outperforming 75.86% of the companies in the same industry.
CLI's Return On Invested Capital of 11.61% is amongst the best of the industry. CLI outperforms 94.83% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CLI is below the industry average of 7.19%.
The last Return On Invested Capital (11.61%) for CLI is above the 3 year average (4.02%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.8%
ROE 14.22%
ROIC 11.61%
ROA(3y)0.98%
ROA(5y)1.12%
ROE(3y)3.7%
ROE(5y)4.3%
ROIC(3y)4.02%
ROIC(5y)3.66%
CLI.MI Yearly ROA, ROE, ROICCLI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

CLI's Profit Margin of 1.88% is on the low side compared to the rest of the industry. CLI is outperformed by 60.34% of its industry peers.
In the last couple of years the Profit Margin of CLI has grown nicely.
Looking at the Operating Margin, with a value of 3.71%, CLI is in line with its industry, outperforming 43.10% of the companies in the same industry.
In the last couple of years the Operating Margin of CLI has grown nicely.
With a Gross Margin value of 19.29%, CLI is not doing good in the industry: 75.86% of the companies in the same industry are doing better.
CLI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.71%
PM (TTM) 1.88%
GM 19.29%
OM growth 3Y15.43%
OM growth 5YN/A
PM growth 3Y16.01%
PM growth 5YN/A
GM growth 3Y-0.63%
GM growth 5Y-14.6%
CLI.MI Yearly Profit, Operating, Gross MarginsCLI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CLI is creating value.
Compared to 1 year ago, CLI has about the same amount of shares outstanding.
The number of shares outstanding for CLI remains at a similar level compared to 5 years ago.
The debt/assets ratio for CLI is higher compared to a year ago.
CLI.MI Yearly Shares OutstandingCLI.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CLI.MI Yearly Total Debt VS Total AssetsCLI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 2.52 indicates that CLI is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.52, CLI is in the better half of the industry, outperforming 62.07% of the companies in the same industry.
The Debt to FCF ratio of CLI is 6.36, which is on the high side as it means it would take CLI, 6.36 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.36, CLI is in line with its industry, outperforming 46.55% of the companies in the same industry.
CLI has a Debt/Equity ratio of 0.56. This is a neutral value indicating CLI is somewhat dependend on debt financing.
CLI has a Debt to Equity ratio of 0.56. This is comparable to the rest of the industry: CLI outperforms 55.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 6.36
Altman-Z 2.52
ROIC/WACC2.43
WACC4.77%
CLI.MI Yearly LT Debt VS Equity VS FCFCLI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 0.86 indicates that CLI may have some problems paying its short term obligations.
CLI has a Current ratio of 0.86. This is amonst the worse of the industry: CLI underperforms 81.03% of its industry peers.
A Quick Ratio of 0.69 indicates that CLI may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.69, CLI is doing worse than 67.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.69
CLI.MI Yearly Current Assets VS Current LiabilitesCLI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

More info and screens

6

3. Growth

3.1 Past

CLI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.71%, which is quite impressive.
Measured over the past years, CLI shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.63% on average per year.
CLI shows a small growth in Revenue. In the last year, the Revenue has grown by 4.69%.
The Revenue has been growing by 14.83% on average over the past years. This is quite good.
EPS 1Y (TTM)35.71%
EPS 3Y24.63%
EPS 5YN/A
EPS Q2Q%33.26%
Revenue 1Y (TTM)4.69%
Revenue growth 3Y7.26%
Revenue growth 5Y14.83%
Sales Q2Q%12.16%

3.2 Future

Based on estimates for the next years, CLI will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.31% on average per year.
Based on estimates for the next years, CLI will show a small growth in Revenue. The Revenue will grow by 3.36% on average per year.
EPS Next Y-2.22%
EPS Next 2Y15.47%
EPS Next 3Y15.31%
EPS Next 5YN/A
Revenue Next Year8.24%
Revenue Next 2Y4.56%
Revenue Next 3Y3.36%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CLI.MI Yearly Revenue VS EstimatesCLI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
CLI.MI Yearly EPS VS EstimatesCLI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6 0.8

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

CLI is valuated cheaply with a Price/Earnings ratio of 4.34.
Based on the Price/Earnings ratio, CLI is valued cheaply inside the industry as 96.55% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 28.88. CLI is valued rather cheaply when compared to this.
CLI is valuated cheaply with a Price/Forward Earnings ratio of 6.84.
Based on the Price/Forward Earnings ratio, CLI is valued cheaper than 86.21% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.20, CLI is valued rather cheaply.
Industry RankSector Rank
PE 4.34
Fwd PE 6.84
CLI.MI Price Earnings VS Forward Price EarningsCLI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLI indicates a rather cheap valuation: CLI is cheaper than 100.00% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLI indicates a rather cheap valuation: CLI is cheaper than 93.10% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.25
EV/EBITDA 2.25
CLI.MI Per share dataCLI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The decent profitability rating of CLI may justify a higher PE ratio.
A more expensive valuation may be justified as CLI's earnings are expected to grow with 15.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.47%
EPS Next 3Y15.31%

More info and screens

0

5. Dividend

5.1 Amount

CLI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CENTRALE DEL LATTE D'ITALIA

BIT:CLI (4/29/2025, 7:00:00 PM)

3.04

+0.16 (+5.56%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.01%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap42.56M
Analysts80
Price Target5.81 (91.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)39.02%
PT rev (3m)39.02%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-18.52%
EPS NY rev (3m)-18.52%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)7.16%
Revenue NY rev (3m)7.16%
Valuation
Industry RankSector Rank
PE 4.34
Fwd PE 6.84
P/S 0.08
P/FCF 3.25
P/OCF 2.59
P/B 0.62
P/tB 0.86
EV/EBITDA 2.25
EPS(TTM)0.7
EY23.03%
EPS(NY)0.44
Fwd EY14.62%
FCF(TTM)0.93
FCFY30.75%
OCF(TTM)1.17
OCFY38.58%
SpS37.15
BVpS4.92
TBVpS3.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.8%
ROE 14.22%
ROCE 16.47%
ROIC 11.61%
ROICexc 18.89%
ROICexgc 25.91%
OM 3.71%
PM (TTM) 1.88%
GM 19.29%
FCFM 2.52%
ROA(3y)0.98%
ROA(5y)1.12%
ROE(3y)3.7%
ROE(5y)4.3%
ROIC(3y)4.02%
ROIC(5y)3.66%
ROICexc(3y)6.06%
ROICexc(5y)5.59%
ROICexgc(3y)8.01%
ROICexgc(5y)7.3%
ROCE(3y)5.7%
ROCE(5y)5.19%
ROICexcg growth 3Y32.21%
ROICexcg growth 5YN/A
ROICexc growth 3Y30.06%
ROICexc growth 5YN/A
OM growth 3Y15.43%
OM growth 5YN/A
PM growth 3Y16.01%
PM growth 5YN/A
GM growth 3Y-0.63%
GM growth 5Y-14.6%
F-Score7
Asset Turnover2.02
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 6.36
Debt/EBITDA 1.11
Cap/Depr 21.57%
Cap/Sales 0.64%
Interest Coverage 5.89
Cash Conversion 47.24%
Profit Quality 133.55%
Current Ratio 0.86
Quick Ratio 0.69
Altman-Z 2.52
F-Score7
WACC4.77%
ROIC/WACC2.43
Cap/Depr(3y)17.55%
Cap/Depr(5y)36.42%
Cap/Sales(3y)0.86%
Cap/Sales(5y)2.07%
Profit Quality(3y)1366.96%
Profit Quality(5y)1110.01%
High Growth Momentum
Growth
EPS 1Y (TTM)35.71%
EPS 3Y24.63%
EPS 5YN/A
EPS Q2Q%33.26%
EPS Next Y-2.22%
EPS Next 2Y15.47%
EPS Next 3Y15.31%
EPS Next 5YN/A
Revenue 1Y (TTM)4.69%
Revenue growth 3Y7.26%
Revenue growth 5Y14.83%
Sales Q2Q%12.16%
Revenue Next Year8.24%
Revenue Next 2Y4.56%
Revenue Next 3Y3.36%
Revenue Next 5YN/A
EBIT growth 1Y17.84%
EBIT growth 3Y23.81%
EBIT growth 5YN/A
EBIT Next Year155.74%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-62.61%
FCF growth 3Y-17.37%
FCF growth 5YN/A
OCF growth 1Y-55.87%
OCF growth 3Y-18.49%
OCF growth 5Y10.4%